The FDA has granted breakthrough therapy designation status to a new Janus kinase 1 inhibitor for the treatment of moderate to severe atopic dermatitis.   READ MORE

Collaborating Associations

Business Insider Series

Lawrence Eichenfield, MD, reports on major developments in the changing field of pediatric dermatology.

Aesthetics Corner

The American Academy of Facial Plastic and Reconstructive Surgery conducted a recent survey to assess trends among cosmetic surgery patients.